查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1618957

神經刺激設備的全球市場:產業分析，規模，佔有率，成長，趨勢，預測(2024年～2031年)

Neurostimulation Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 177 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計2024年全球神經刺激設備市場規模將達到67億美元，2024年至2031年的預測期內複合年增長率為11.7%，預計到2031年將達到146億美元。

神經刺激器對於治療各種神經系統疾病和病症至關重要，包括慢性疼痛、癲癇、帕金森氏症和憂鬱症。這些設備為神經系統的特定區域提供電刺激，調節神經活動，緩解症狀，並改善患者的生活品質。神經刺激設備市場提供脊髓刺激器、深部腦部刺激器和迷走神經刺激器等多種設備，並且與醫院、診所和家庭護理環境相容。神經系統疾病的日益普及、設備技術的進步以及人們對神經刺激作為有效治療工具的認識不斷增強，推動了市場的成長。

全球神經刺激設備市場由幾個關鍵因素推動，包括慢性疼痛以及癲癇和帕金森氏症等神經系統疾病盛行率的上升。對微創治療方案的需求不斷增長，以及設備小型化、充電電池和無線連接方面的進步，正在提高患者的舒適度並提高市場採用率。此外，老年人口的增加和醫療保健成本的上升正在推動對有效和長期神經治療的需求，進一步推動市場成長。

神經刺激器市場的重大機會源自於技術進步、應用範圍擴大和有利的人口趨勢。設備設計的創新正在釋放新的可能性，包括非侵入性刺激技術、人工智慧的整合以及改進的患者監測能力。神經刺激在肥胖管理、中風復健和偏頭痛治療等領域的新興應用正在擴大市場範圍。此外，研發投資的增加以及產業參與者之間的策略聯盟正在為動態神經刺激市場的成長和創新創造道路。

本報告提供全球神經刺激設備市場相關調查，提供各產品類型，各用途，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍和定義
  • 市場動態
  • 宏觀經濟要素
  • COVID-19影響分析
  • 預測要素- 相關性及影響

第3章 附加價值的洞察

  • 產品招聘分析
  • 技術評估
  • 法規情形
  • 價值鏈分析
  • 主要的交易合併
  • 大環境分析
  • 波特的五力分析

第4章 價格趨勢分析，2019年～2031年

第5章 全球神經刺激設備市場預測:實際成果(2019年～2023年)及預測(2024年～2031年)

  • 主要的焦點
  • 市場規模(10億美元)分析與預測
  • 全球神經刺激設備市場預測:各產品類型
  • 全球神經刺激設備市場預測:各用途
  • 市場魅力分析:各用途
  • 全球神經刺激設備市場預測:各終端用戶
  • 市場魅力分析:各終端用戶

第6章 全球神經刺激設備市場預測:各地區

  • 主要的焦點
  • 過去的市場規模(10億美元)和數量(台)的分析，各地區，2019年～2023年
  • 目前市場規模(10億美元)和數量(台)的分析與預測，各地區，2023年～2031年
  • 市場魅力分析:各地區

第7章 北美的神經刺激設備市場預測:實際成果(2019年～2023年)及預測(2024年～2031年)

第8章 歐洲的神經刺激設備市場預測:實際成果(2019年～2023年)及預測(2024年～2031年)

第9章 東亞的神經刺激設備市場預測:實際成果(2019年～2023年)及預測(2024年～2031年)

第10章 南亞及大洋洲的神經刺激設備市場預測:實際成果(2019年～2023年)及預測(2024年～2031年)

第11章 南美的神經刺激設備市場預測:實際成果(2019年～2023年)及預測(2024年～2031年)

第12章 中東·非洲的神經刺激設備市場預測:實際成果(2019年～2023年)及預測(2024年～2031年)

第13章 競爭情形

  • 市場佔有率分析，2023年
  • 市場結構
  • 企業簡介(詳細內容- 概要，財務，策略，最近的趨勢)
    • Medtronic
    • Abbott
    • Boston Scientific Corporation
    • Cochlear Inc.
    • NDI Medical LLC
    • NeuroPace Inc.
    • MED-EL Medical Electronics
    • NeuroSigma Inc.

第14章 附錄

簡介目錄
Product Code: PMRREP2824

Persistence Market Research has recently released a comprehensive report on the worldwide market for neurostimulation devices. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global neurostimulation devices market from 2024 to 2031.

Key Insights:

  • Neurostimulation Devices Market Size (2024E):US$ 6.7 Bn
  • Projected Market Value (2031F): US$ 14.6 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 11.7%

Neurostimulation Devices Market - Report Scope:

Neurostimulation devices are critical in treating various neurological disorders and conditions, including chronic pain, epilepsy, Parkinson's disease, and depression. These devices deliver electrical stimulation to specific areas of the nervous system to modulate neural activity, alleviate symptoms, and improve patient quality of life. The neurostimulation devices market caters to hospitals, clinics, and homecare settings, offering a variety of devices such as spinal cord stimulators, deep brain stimulators, and vagus nerve stimulators. Market growth is driven by the increasing prevalence of neurological disorders, advancements in device technology, and growing awareness of neurostimulation as an effective treatment modality.

Market Growth Drivers:

The global neurostimulation devices market is propelled by several key factors, including the rising incidence of chronic pain and neurological disorders, such as epilepsy and Parkinson's disease. Increasing demand for minimally invasive treatment options and advancements in device miniaturization, rechargeable batteries, and wireless connectivity are enhancing patient comfort and expanding market adoption. Additionally, the growing geriatric population and increasing healthcare expenditure are driving the demand for effective and long-term neurological treatments, further fueling market growth.

Market Restraints:

Despite promising growth prospects, the neurostimulation devices market faces challenges, including high device costs, regulatory hurdles, and potential side effects associated with neurostimulation therapy. Limited access to advanced healthcare infrastructure in developing regions and the lengthy approval process for new devices can restrict market growth. Furthermore, reimbursement constraints and patient skepticism regarding device implantation present additional barriers to widespread adoption.

Market Opportunities:

Significant opportunities in the neurostimulation devices market stem from technological advancements, expanding applications, and favorable demographic trends. Innovations in device design, such as non-invasive stimulation techniques, artificial intelligence integration, and improved patient monitoring capabilities, are unlocking new potential. Emerging applications of neurostimulation in conditions like obesity management, stroke rehabilitation, and migraine treatment broaden the market scope. Moreover, increasing investments in R&D and strategic collaborations among industry players create pathways for growth and innovation in the dynamic neurostimulation landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the neurostimulation devices market globally?
  • Which device types and applications are propelling neurostimulation adoption across various healthcare settings?
  • How are technological advancements shaping the competitive landscape of the neurostimulation devices market?
  • Who are the key players in the market, and what strategies are they employing to maintain competitiveness?
  • What are the emerging trends and future prospects in the global neurostimulation devices market?

Competitive Intelligence and Business Strategy:

Leading players in the global neurostimulation devices market, including Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, and Nevro Corp., focus on innovation and strategic partnerships to strengthen their market positions. These companies are investing heavily in R&D to develop advanced neurostimulation solutions, such as closed-loop systems, wearable stimulators, and devices with enhanced connectivity. Collaborations with healthcare providers, research institutions, and regulatory agencies enable market access and facilitate the adoption of cutting-edge technologies. Emphasis on patient education, clinical research, and evidence-based practice further supports market expansion and improved patient outcomes.

Key Companies Profiled:

  • Medtronic PLC
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Nevro Corp.
  • LivaNova PLC
  • Cyberonics, Inc.
  • Stimwave LLC
  • NeuroPace, Inc.
  • Synapse Biomedical Inc.

Neurostimulation Devices Industry Segmentation

By Product Type

  • Spinal Cord Stimulators (SCS)
  • Deep Brain Stimulators (DBS)
  • Vagus Nerve Stimulators (VNS)
  • Sacral Nerve Stimulators
  • Transcranial Magnetic Stimulation (TMS) Devices
  • Transcutaneous Electrical Nerve Stimulation (TENS) Devices

By Application

  • Pain Management
  • Epilepsy
  • Depression
  • Parkinson's Disease

By End User

  • Hospitals
  • Clinics
  • Homecare Settings
  • Research Institutes

By Region

  • North America
  • Europe
  • Latin America
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Neurostimulation Devices Market Snapshot, 2024 and 2031
  • 1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Technology Assessment
  • 3.3. Regulatory Landscape
  • 3.4. Value Chain Analysis
  • 3.5. Key Deals and Mergers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Price Trend Analysis, 2019 - 2031

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product Type
  • 4.4. Regional Prices and Product Type Preferences

5. Global Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2023
    • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024 - 2031
  • 5.3. Global Neurostimulation Devices Market Outlook: Product Type
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product Type, 2019 - 2023
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
      • 5.3.3.1. Spinal Cord Stimulators (SCS)
      • 5.3.3.2. Deep Brain Stimulators (DBS)
      • 5.3.3.3. Vagus Nerve Stimulators (VNS)
      • 5.3.3.4. Sacral Nerve Stimulators
      • 5.3.3.5. Transcranial Magnetic Stimulation (TMS) Devices
      • 5.3.3.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
    • 5.3.4. Market Attractiveness Analysis: Product Type
  • 5.4. Global Neurostimulation Devices Market Outlook: Application
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
    • 5.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
      • 5.4.3.1. Pain Management
      • 5.4.3.2. Epilepsy
      • 5.4.3.3. Depression
      • 5.4.3.4. Parkinson's Disease
      • 5.4.3.5. Others
  • 5.5. Market Attractiveness Analysis: Application
  • 5.6. Global Neurostimulation Devices Market Outlook: End User
    • 5.6.1. Introduction / Key Findings
    • 5.6.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2023
    • 5.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
      • 5.6.3.1. Hospitals
      • 5.6.3.2. Clinics
      • 5.6.3.3. Homecare Settings
      • 5.6.3.4. Research Institutes
  • 5.7. Market Attractiveness Analysis: End User

6. Global Neurostimulation Devices Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2023
  • 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2023 - 2031
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) and Analysis, By Market, 2019 - 2023
    • 7.2.1. By Country
    • 7.2.2. By Product Type
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 7.4.1. Spinal Cord Stimulators (SCS)
    • 7.4.2. Deep Brain Stimulators (DBS)
    • 7.4.3. Vagus Nerve Stimulators (VNS)
    • 7.4.4. Sacral Nerve Stimulators
    • 7.4.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 7.4.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 7.5.1. Pain Management
    • 7.5.2. Epilepsy
    • 7.5.3. Depression
    • 7.5.4. Parkinson's Disease
    • 7.5.5. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 7.6.1. Hospitals
    • 7.6.2. Clinics
    • 7.6.3. Homecare Settings
    • 7.6.4. Research Institutes
  • 7.7. Market Attractiveness Analysis

8. Europe Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 8.3.1. By Country
    • 8.3.2. By Product Type
    • 8.3.3. By Application
    • 8.3.4. By End User
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. U.K.
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Russia
    • 8.4.7. Turkey
    • 8.4.8. Rest of Europe
  • 8.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 8.5.1. Spinal Cord Stimulators (SCS)
    • 8.5.2. Deep Brain Stimulators (DBS)
    • 8.5.3. Vagus Nerve Stimulators (VNS)
    • 8.5.4. Sacral Nerve Stimulators
    • 8.5.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 8.5.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 8.6.1. Pain Management
    • 8.6.2. Epilepsy
    • 8.6.3. Depression
    • 8.6.4. Parkinson's Disease
    • 8.6.5. Others
  • 8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 8.7.1. Hospitals
    • 8.7.2. Clinics
    • 8.7.3. Homecare Settings
    • 8.7.4. Research Institutes
  • 8.8. Market Attractiveness Analysis

9. East Asia Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 9.3.1. By Country
    • 9.3.2. By Product Type
    • 9.3.3. By Application
    • 9.3.4. By End User
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. South Korea
  • 9.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 9.5.1. Spinal Cord Stimulators (SCS)
    • 9.5.2. Deep Brain Stimulators (DBS)
    • 9.5.3. Vagus Nerve Stimulators (VNS)
    • 9.5.4. Sacral Nerve Stimulators
    • 9.5.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 9.5.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 9.6.1. Pain Management
    • 9.6.2. Epilepsy
    • 9.6.3. Depression
    • 9.6.4. Parkinson's Disease
    • 9.6.5. Others
  • 9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 9.7.1. Hospitals
    • 9.7.2. Clinics
    • 9.7.3. Homecare Settings
    • 9.7.4. Research Institutes
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 10.3.1. India
    • 10.3.2. SEA
    • 10.3.3. ANZ
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 10.4.1. Spinal Cord Stimulators (SCS)
    • 10.4.2. Deep Brain Stimulators (DBS)
    • 10.4.3. Vagus Nerve Stimulators (VNS)
    • 10.4.4. Sacral Nerve Stimulators
    • 10.4.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 10.4.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 10.5.1. Pain Management
    • 10.5.2. Epilepsy
    • 10.5.3. Depression
    • 10.5.4. Parkinson's Disease
    • 10.5.5. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 10.6.1. Hospitals
    • 10.6.2. Clinics
    • 10.6.3. Homecare Settings
    • 10.6.4. Research Institutes

11. Latin America Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 11.3.1. By Country
    • 11.3.2. By Product Type
    • 11.3.3. By Application
    • 11.3.4. By End User
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of Latin America
  • 11.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 11.5.1. Spinal Cord Stimulators (SCS)
    • 11.5.2. Deep Brain Stimulators (DBS)
    • 11.5.3. Vagus Nerve Stimulators (VNS)
    • 11.5.4. Sacral Nerve Stimulators
    • 11.5.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 11.5.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 11.6.1. Pain Management
    • 11.6.2. Epilepsy
    • 11.6.3. Depression
    • 11.6.4. Parkinson's Disease
    • 11.6.5. Others
  • 11.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 11.7.1. Hospitals
    • 11.7.2. Clinics
    • 11.7.3. Homecare Settings
    • 11.7.4. Research Institutes
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 12.3.1. By Country
    • 12.3.2. By Product Type
    • 12.3.3. By Application
    • 12.3.4. By End User
  • 12.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 12.4.1. GCC Countries
    • 12.4.2. Egypt
    • 12.4.3. South Africa
    • 12.4.4. Northern Africa
    • 12.4.5. Rest of Middle East & Africa
  • 12.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 12.5.1. Spinal Cord Stimulators (SCS)
    • 12.5.2. Deep Brain Stimulators (DBS)
    • 12.5.3. Vagus Nerve Stimulators (VNS)
    • 12.5.4. Sacral Nerve Stimulators
    • 12.5.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 12.5.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 12.6.1. Pain Management
    • 12.6.2. Epilepsy
    • 12.6.3. Depression
    • 12.6.4. Parkinson's Disease
    • 12.6.5. Others
  • 12.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 12.7.1. Hospitals
    • 12.7.2. Clinics
    • 12.7.3. Homecare Settings
    • 12.7.4. Research Institutes
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Medtronic
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product Types
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Abbott
    • 13.3.3. Boston Scientific Corporation
    • 13.3.4. Cochlear Inc.
    • 13.3.5. NDI Medical LLC
    • 13.3.6. NeuroPace Inc.
    • 13.3.7. MED-EL Medical Electronics
    • 13.3.8. NeuroSigma Inc.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations